Paris - Topical imiquimod offers safe and often effective treatment for basal cell carcinomas (BCCs) in immunosuppressed, solid organ transplantation patients, David Vidal, M.D., said at the World Congress of Dermatology.
CG and Minoxidil Combination Therapy Shows Promise for AA
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Tackle Sports Dermatoses
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Isotretinoin’s Role in Rosacea Management
Publishing Excellence Runs More Than Skin Deep